Greenland Capital Management LP
Source: SEC Form 13F · as of Mar 2026Greenland Capital Management LP holds 11 biotech & pharma companies tracked by BioSniper, totaling $23.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$23.8M
| Company | Shares | Value |
|---|---|---|
| LQDALiquidia Corp | 214,000 | $8.1M |
| TEVATeva Pharmaceutical Industries Limited | 107,500 | $3.2M |
| BMRNBIOMARIN PHARMACEUTICAL INC | 53,100 | $3.0M |
| MLYSMineralys Therapeutics, Inc. | 83,500 | $2.3M |
| DNLIDenali Therapeutics Inc. | 99,000 | $1.9M |
| RVMDREVOLUTION MEDICINES, INC. | 17,432 | $1.7M |
| VRDNViridian Therapeutics, Inc.\DE | 55,000 | $1.1M |
| BHVNBiohaven Ltd. | 101,200 | $856K |
| CNTACentessa Pharmaceuticals plc | 15,000 | $596K |
| CYTKCYTOKINETICS INC | 9,000 | $593K |
| ABVXAbivax SA | 5,000 | $557K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.